CJC 1295 No DAC Peptide – 5MG

CJC‑1295 (No DAC)  5mg | High‑Purity GHRH Analogue for In‑Vitro Research | Research Use Only

CJC‑1295 (No DAC) — also known as Mod GRF(1–29) — is a short‑acting growth hormone–releasing hormone (GHRH) analogue used in controlled in‑vitro studies of GHRH receptor signalling, cAMP/PKA pathways, and GH‑axis biochemical models. Supplied as a 5 mg lyophilised vial for laboratory research only. Not for human use.

What is CJC‑1295 (No DAC)?

This listing refers specifically to the non‑DAC (short‑acting) variant, Mod GRF(1–29). Researchers select this form to investigate:

• GHRH receptor (GHRHR) engagement
• Ligand–receptor binding dynamics
• cAMP accumulation and PKA activation
• GH‑axis second‑messenger pathways
• Structure–activity relationships (SAR) in cell‑based systems

All applications are restricted to non‑clinical, in‑vitro laboratory environments.

Key Features

• Non‑DAC GHRH analogue (Mod GRF(1–29)) for GH‑axis signalling research
• Ideal for receptor pharmacology, cAMP/PKA pathway studies, and SAR profiling
• Supplied as a stable lyophilised solid for reliable storage
• Unit size: 5 mg per vial
• Each batch undergoes strict internal QC for identity, purity, and appearance
• Provided strictly for laboratory research — not for human or veterinary use

Specifications

• Product name: CJC‑1295 (No DAC) / Mod GRF(1–29)
• Synonyms: CJC‑1295 no DAC; Mod GRF(1–29); tetrasubstituted GRF(1–29)
• Class: Growth hormone–releasing hormone analogue (non‑DAC)
• Form: Lyophilised powder
• Appearance: White to off‑white solid
• Note: Exact properties may vary by counter‑ion and hydration state. Refer to vial label for batch‑specific details.

Handling & Storage

• Dry storage: Store vials protected from light and moisture
• Reconstitution: Bring vial and diluent to room temperature; reconstitute with Bacteriostatic Water 10 ml; swirl gently — do not vortex
• After reconstitution: Store at 2–8 °C, protect from light, prepare aliquots to minimise freeze–thaw cycles
• Compatibility: Use only within validated research protocols aligned with institutional SOPs and local regulations

Research Applications

CJC‑1295 (No DAC) is used in controlled in‑vitro systems to investigate:

• GHRHR binding and receptor pharmacology
• cAMP accumulation and PKA activation
• GH‑axis transcriptional responses
• Comparative SAR profiling
• Short‑acting GHRH analogue behaviour

Studies focus exclusively on non‑clinical, in‑vitro environments.

Certificate of Analysis (COA)

Each lot of CJC‑1295 (No DAC) undergoes internal QC checks for identity, purity, and appearance before release. COA available upon request for qualified research institutions.

Synthesis & Quality Assurance

CJC‑1295 (No DAC) is manufactured through validated peptide‑synthesis processes designed for:

• High purity
• Lot‑to‑lot consistency
• Reliable performance in biochemical and cell‑based assays

Every batch is reviewed under strict internal quality standards.

Related Research Materials

• Bacteriostatic Water 10 ml
• Ipamorelin 5 mg
• GHRP‑6 5 mg

Internal linking boosts SEO and helps researchers find complementary GH‑axis materials.

Why Choose Pep Lab London?

• ISO‑aligned internal QC
• Clinical‑white branding and transparent sourcing
• Research‑only compliance
• Fast UK shipping
• Trusted by GH‑axis and receptor‑signalling research labs

Legal & Safety Notice

Pep Lab London supplies materials strictly for laboratory research. Products are not medications, foods, supplements, or cosmetics, and must not be used in humans or animals. By purchasing, you confirm you are a qualified researcher and will handle the material according to institutional policies and applicable regulations.

Disclaimer

This material is intended solely for in‑vitro research and cannot be:

• Used in clinical studies involving humans
• Administered to humans in any form
• Supplied to any party for human investigational use